NASDAQ:SBTX Shareholder Notice: Lawsuit Alleges Misleading Statements by Silverback Therapeutics, Inc.
An investor, who purchased shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX), filed a lawsuit over alleged violations of Federal Securities Laws by Silverback Therapeutics, Inc.
View full press release